The Checkup by Singlecare
JULY 9, 2024
A meta-analysis published in Diabetes, Obesity, and Metabolism in 2014 found that empagliflozin, the active ingredient in Jardiance, is effective at controlling blood sugar and reducing body weight and blood pressure. Jardiance vs Trulicity: Cost Jardiance is more affordable than Trulicity before insurance or discounts. for 4, 1.5-mg/0.5
The Checkup by Singlecare
DECEMBER 31, 2024
In fact, a 2019 study demonstrated that this combination therapy is more effective than glimepiride alone, while a study from 2014 showed that its more effective than metformin uptitration (the gradual increase of dosage). Morkos , Pharm.D. of Marshall B. Ketchum University.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
MARCH 21, 2024
Wegovy is the first weight loss medication approved by the Food and Drug Administration since 2014. To verify whether your BCBS plan will cover Wegovy, check with your insurance company or your employer if you have employer-sponsored coverage.
The Checkup by Singlecare
OCTOBER 3, 2024
The Food and Drug Administration (FDA) approved Belsomra in 2014 , making it a potential treatment option for patients struggling with sleep issues. Without insurance, the most common dosage of Belsomra may cost more than $600 per month. Several factors can affect insurance coverage for Belsomra.
The Checkup by Singlecare
OCTOBER 16, 2024
Contrave is made by Currax Pharmaceuticals and was approved by the Food and Drug Administration (FDA) in 2014. This medicine works on parts of the brain associated with appetite and reward, although the exact way it works is not completely understood.
The Checkup by Singlecare
AUGUST 21, 2024
Belsomra was the first DORA, approved by the Food and Drug Administration (FDA) in 2014. RELATED: Quviviq vs. Ambien Quviviq vs. Belsomra: Insurance coverage and cost comparison Belsomra may have wider acceptance among insurance plans than Quviviq, as it’s an older, more established drug.
The Checkup by Singlecare
OCTOBER 3, 2024
It wasn’t until 2014 when a GLP-1 first received FDA approval for weight loss—Saxenda (liraglutide). Another benefit of this medication is that for those without insurance coverage, single-agent formulations exist for both components of Qsymia and are typically much less expensive than the combined formulation.
Expert insights. Personalized for you.
92 
Let's personalize your content